These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1221 related items for PubMed ID: 18799960

  • 1. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

  • 2. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN, Merchant R.
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [Abstract] [Full Text] [Related]

  • 3. Dietary therapy in polycystic ovary syndrome.
    Moran LJ, Brinkworth GD, Norman RJ.
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [Abstract] [Full Text] [Related]

  • 4. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).
    Giallauria F, Palomba S, Maresca L, Vuolo L, Tafuri D, Lombardi G, Colao A, Vigorito C, Francesco O.
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):792-8. PubMed ID: 18505468
    [Abstract] [Full Text] [Related]

  • 5. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF.
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [Abstract] [Full Text] [Related]

  • 6. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B, Gambineri A, Pasquali R.
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A, Amato MC, Giordano C.
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [Abstract] [Full Text] [Related]

  • 8. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F, Vuolo L, Palomba S, Lombardi G, Colao A.
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [Abstract] [Full Text] [Related]

  • 9. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, Kränzlin M, Puder JJ.
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [Abstract] [Full Text] [Related]

  • 10. Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician.
    Lorenz LB, Wild RA.
    Clin Obstet Gynecol; 2007 Mar; 50(1):226-43. PubMed ID: 17304038
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovary syndrome and the postmenopausal woman.
    Ireland K, Child T.
    J Br Menopause Soc; 2006 Dec; 12(4):143-8. PubMed ID: 17178014
    [Abstract] [Full Text] [Related]

  • 12. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
    Sharma ST, Nestler JE.
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
    [Abstract] [Full Text] [Related]

  • 13. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.
    Moran L, Norman RJ.
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):719-36. PubMed ID: 15380143
    [Abstract] [Full Text] [Related]

  • 14. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [Abstract] [Full Text] [Related]

  • 15. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
    Alexander CJ, Tangchitnob EP, Lepor NE.
    Rev Cardiovasc Med; 2009 Aug; 10(2):83-90. PubMed ID: 19593320
    [Abstract] [Full Text] [Related]

  • 16. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF, Nilas L, Nørgaard K, Madsbad S.
    Ugeskr Laeger; 2005 Aug 22; 167(34):3147-51. PubMed ID: 16117910
    [Abstract] [Full Text] [Related]

  • 17. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
    Rabelo Acevedo M, Vick MR.
    P R Health Sci J; 2005 Sep 22; 24(3):203-6. PubMed ID: 16329683
    [Abstract] [Full Text] [Related]

  • 18. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.
    Cattrall FR, Healy DL.
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct 22; 18(5):803-12. PubMed ID: 15380148
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk in women with polycystic ovary syndrome.
    Orio F, Palomba S, Colao A.
    Fertil Steril; 2006 Jul 22; 86 Suppl 1():S20-1. PubMed ID: 16798279
    [Abstract] [Full Text] [Related]

  • 20. Metabolic syndrome in polycystic ovary syndrome.
    Carmina E.
    Minerva Ginecol; 2006 Apr 22; 58(2):109-14. PubMed ID: 16582867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.